Anesthesia CBD by Pyramid Seeds
Anesthesia (Pyramid Seeds) × Unknown Strain
Anesthesia CBD by Pyramid Seeds is a predominantly indica cultivar bred for balanced potency and profound physical relaxation. It is characterized by a 1:1 style chemotype, offering calm and body relief without heavy intoxication, making it suitable for those seeking comfort and clarity.
Appearance and Morphology
Anesthesia CBD plants typically grow short to medium in height, with a compact and bushy structure that responds well to training. The leaves are broad and dark green, indicative of its indica heritage, and some phenotypes may display purple hues under cooler night temperatures. The flowers are conical with a high calyx-to-leaf ratio, densely packed with trichomes, giving them a frosted appearance.
The dried buds are firm and resinous, possessing a classic indica density. They break apart with a satisfying texture, often leaving fingers sticky due to their significant trichome coverage. This strain's appearance is characterized by a glossy, sugar-coated look under magnification, contributing to its visual appeal.
Aroma and Flavor
The aroma of Anesthesia CBD is primarily earthy and sweet, with prominent hash-like undertones. It is layered with notes of pepper and subtle hints of pine and citrus. This complex bouquet is largely driven by its terpene profile, which includes myrcene and caryophyllene.
The flavor profile mirrors the aroma, offering a taste reminiscent of classic Afghan hash with a refined, modern finish. Consumers can expect a blend of earthy, sweet, and slightly peppery notes, with occasional citrus or coffee-like nuances.
Effects
Anesthesia CBD is known for delivering a gentle and steady onset of effects, leading to a clear-headed plateau that is generally described as comfortable rather than overwhelming. The presence of CBD helps to temper the psychoactivity of THC, promoting a sense of calm and deep physical relaxation.
This balanced profile makes it a favored choice for consumers seeking tangible body relief and a tranquil state without the heavy sedation often associated with high-THC indica strains. It is considered an evening staple that can provide comfort while preserving mental clarity.
Terpenes and Cannabinoids
Anesthesia CBD is characterized by a balanced cannabinoid profile, often presenting in a 1:1 ratio of THC to CBD, with THC levels typically ranging from 15-25% and CBD below 1%. Its terpene composition is dominated by myrcene and beta-caryophyllene, with secondary contributions from limonene and alpha-pinene.
The terpene profile contributes significantly to the strain's aroma and effects. Myrcene provides earthy and herbal notes, while beta-caryophyllene adds a peppery spice. Limonene contributes citrusy aromas, and pinene offers a fresh pine scent.
Growing Characteristics
Anesthesia CBD is valued by growers for its compact structure, forgiving nutrient requirements, and respectable yields, especially for a CBD-rich line. It typically grows short to medium in height, with plants averaging 80–120 cm indoors when untrained. The strain features strong apical dominance and tight internodal spacing, supporting dense cola formation.
It exhibits robust trichome production and prefers well-aerated media, rewarding timely up-potting. The indica-dominant genetics suggest a preference for cooler night temperatures late in the flowering cycle, which can enhance color expression. Overall, it is considered a practical choice for both novice and experienced indoor growers.
Origins and Lineage
Anesthesia CBD was developed by Pyramid Seeds as a CBD-forward variation of their original Anesthesia strain. The lineage is indica-dominant, drawing influences from Afghan landrace genetics and classic northern broadleaf varieties, selected for resin density, structure, and rapid finishing times.
While the exact parentage of the CBD donor is not fully disclosed, some sources suggest it involves crosses with strains like Guide Dawg. This breeding effort aimed to retain the comforting qualities of the original Anesthesia while incorporating a balanced cannabinoid profile for therapeutic versatility and broader consumer appeal.